Identifying the Best Treatments

for Patients with Rare Cancers

Rare cancers present special challenges for patients and their physicians.  Owing to a dearth of clinical trials in most rare cancer types chemotherapy options are often few.  Add to that the fact that most oncologists seldom encounter many of the rare cancers and the task of choosing an effective treatment becomes extremely difficult.

Here is where cytometric profiling becomes highly useful.  Bypassing the need for clinical trials, cytometric profiling can pinpoint the most highly promising, personalized chemotherapy treatment for each patient by observing how a wide range of drugs in all classes - standard cytotoxic, immunologic, kinase targeted, and anti-angiogenic - work against the patient’s own, living tumor cells.

Cytometric tumor profiling takes the guesswork out of choosing effective treatments for patients with rare cancer types.